The Academy has a long history of providing objective technical expertise on health insurance regulatory issues, leveraging our members’ professional expertise and familiarity with health insurance from a variety of perspectives. The intent of this letter, therefore, is not to advocate for a particular approach but, rather, to explore different alternatives and provide input on the advantages and disadvantages of those alternatives. The work group that developed this letter Dear Dr. Buntin: